SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549


                                    FORM 10-Q

         Quarterly  report  pursuant  to Section  13 or 15(d) of the  Securities
         Exchange Act of 1934. For the quarter ended June 30, 1996.

                         Commission file number 1-11388


                                PLC SYSTEMS INC.
             (Exact name of registrant as specified in its charter)


BRITISH COLUMBIA, CANADA                                 04-3153858
(State or other jurisdiction of             (I.R.S. Employer Identification No.)
  incorporation or organization)

113 CEDAR STREET, SUITE S-2, MILFORD, MASSACHUSETTS               01757
(Address of principal executive offices)                        (Zip Code)

       Registrant's telephone number, including area code: (508) 478-5991

                                ----------------

Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days. YES X  NO   .
                                      ---   ---


                      APPLICABLE ONLY TO CORPORATE ISSUERS:


Indicate  the  number of shares  outstanding  of each of the  issuer's  class of
common stock, as of the latest practical date.

         Class                               Outstanding at August 9, 1996
         -----                               -----------------------------
  Common Stock, no par value                           16,455,219







                                PLC SYSTEMS INC.

                                      INDEX




              

Part I.  Financial Information:

         Item 1.
                                                                                                       
               Consolidated Balance Sheets.................................................................3

               Consolidated Statements of Operations.......................................................4

               Consolidated Statements of Cash Flows.......................................................5

               Notes to Consolidated Financial Statements..................................................6


         Item 2.  Management's Discussion and Analysis
                    of Financial Condition and Results of Operations....................................7-10


Part II.     Other Information:

         Item 1.    Legal Proceedings.....................................................................11

         Item 2.    Changes in Securities.................................................................11

         Item 3.    Defaults by the Company Upon its Senior Securities....................................11

         Item 4.    Submission of Matters to a Vote of Security Holders...................................11

         Item 5.    Other Information.....................................................................12

         Item 6.    Exhibits and Reports on Form 8-K..................................................... 12







ITEM 1.  FINANCIAL STATEMENTS


                                PLC SYSTEMS INC.
                           CONSOLIDATED BALANCE SHEETS
                                 (In thousands)




                                                                     June 30,       December 31,
                                                                       1996            1995
                                                                       ----            ----
                                                                   (Unaudited)
                                     ASSETS
                                                                                     
Current assets:
    Cash and cash equivalents..................................      $ 4,307          $   704  
    Short-term investments.....................................        9,441            6,500
    Accounts receivable, net...................................          829            6,749
    Inventories, net ..........................................        2,889            1,789
    Prepaid expenses and other current assets..................        1,152              488
                                                                     -------          -------
       Total current assets....................................       18,618           16,230
                                                        
Equipment, furniture and leasehold improvements, net  .........        2,302            1,692
Other assets...................................................          346              368
                                                                     -------          -------
       Total assets............................................      $21,266          $18,290
                                                                     =======          =======


                      LIABILITIES AND STOCKHOLDERS' EQUITY

Current liabilities:
    Accounts payable...........................................     $  1,406        $     546
    Accrued clinical costs.....................................          852              854
    Accrued compensation.......................................          194              777
    Deferred revenue...........................................           79              166
    Other accrued liabilities..................................          394              346
                                                                     -------          -------
       Total current liabilities...............................        2,925            2,689

Deferred revenue...............................................          254               61
Capital lease obligations .....................................           27               32
Commitments and contingencies

Stockholders' equity:
Common stock, no par value,  25,000 shares authorized,  16,455 
    and 15,944 shares issued and outstanding in 1996 and 1995,
    respectively...............................................       53,786           51,411
Accumulated deficit............................................      (35,215)         (35,589)
Foreign currency translation...................................         (511)            (314)
                                                                     -------          -------
                                                                      18,060           15,508
                                                                     -------          -------
Total liabilities and stockholders' equity.....................     $ 21,266         $ 18,290
                                                                    ========         ========



         The accompanying notes are an integral part of the consolidated
                             financial statements.




   
                                       -3-




                                PLC SYSTEMS INC.
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                      (In thousands, except per share data)





                                                       Three Months Ended           Six Months Ended
                                                             June 30,                   June 30,
                                                             --------                   --------

                                                       1996          1995          1996          1995      
                                                       ----          ----          ----          ----
                                                                                       
Revenues:                                                                                    
 Product sales.................................        $ 769        $1,164        $4,966        $3,878     
 Placement and service fees....................          662           323         1,294           477     
                                                      ------        ------        ------        ------
      Total revenues ..........................        1,431         1,487         6,260         4,355
                                                                                             
                                                                                             
Cost of revenues:                                                                            
 Product sales.................................          174           592         1,260         1,656
 Placement and service fees....................          202            25           506            51
                                                      ------        ------        ------        ------
   Total cost of revenues......................          376           617         1,766         1,707
                                                                                             
                                                                                             
Gross profit...................................        1,055           870         4,494         2,648
                                                                                             
Operating expenses:                                                                          
 Selling, general and administrative...........        1,591         1,110         3,042         2,127
 Research and development......................          559           503         1,318         1,258
                                                      ------        ------        ------        ------
   Total operating expenses....................        2,150         1,613         4,360         3,385
                                                      ------        ------        ------        ------
                                                                                             
Income (loss) from operations..................       (1,095)         (743)          134          (737)
                                                                                             
Other income:                                                                                
 Interest income, net..........................          161           165           299           321
 Gain (loss) from foreign currency, net........           16             -           (55)            -
                                                      ------        ------        ------        ------  
                                                         177           165           244           321
                                                      ------        ------        ------        ------
                                                                                             
Income (loss) before income taxes..............         (918)         (578)          378          (416)
Provision for income taxes.....................          (15)            -             4             -
                                                      ------        ------        ------        ------
Net income (loss)..............................       $ (903)       $ (578)       $  374        $ (416)
                                                      ======        ======        ======        ======
                                                                                             
Net income (loss) per share....................       $(0.05)       $(0.04)       $ 0.02        $(0.03)
                                                                                             
Shares used to compute net income (loss)                                                     
 per share.....................................   16,441,000    15,849,000    17,214,000    15,847,000
                                                                                           





         The accompanying notes are an integral part of the consolidated
                              financial statements.


                                      -4-




                                PLC SYSTEMS INC.
                      CONSOLIDATED STATEMENTS OF CASH FLOWS
                                 (In thousands)





                                                             Six  Months Ended
                                                                  June 30,
                                                            -------------------
                                                            1996          1995
Operating activities:                                       ----          ----
  Net income (loss)..................................      $  374         $(416)

  Adjustments to reconcile net income to net cash 
  provided (used) for operating activities:
   Depreciation and amortization.....................         524           164
   Change in assets and liabilities:              
     Decrease (increase) in accounts receivable......       5,920          (128)
     Increase in inventory...........................      (1,100)       (1,170)
     Increase in prepaid expenses and other assets...        (654)          (62)
     Increase in accounts payable....................         860           327
     Increase (decrease) in deferred revenue.........         106           (11)
     (Decrease) increase in accrued liabilities......        (538)          611
                                                          -------        ------
Net cash provided (used) for operating activities....       5,492          (685)

Investing activities:                             
  Purchase of short-term investments.................     (16,442)       (8,181)
  Maturities of short-term investments...............      13,501         7,857
  Purchase of fixed assets...........................      (1,122)         (264)
                                                          -------        ------
Net cash used for investing activities...............      (4,063)         (588)

Financing activities:
  Net proceeds from sales of shares..................       2,264            37
  Repayment of stockholder notes.....................         110            56
  Principal payments on capital lease obligations....          (4)           (4)
                                                          -------       -------
Net cash provided by financing activities............       2,370            89

Effect of exchange rate changes on cash 
    and cash equivalents.............................        (196)           34
                                                          -------       -------
Net increase(decrease) in cash and cash equivalents..       3,603        (1,150)

Cash and cash equivalents at beginning of period.....         704         3,699
                                                          -------       -------
Cash and cash equivalents at end of period...........     $ 4,307        $2,549
                                                          =======       =======






         The accompanying notes are an integral part of the consolidated
                             financial statements.


                                      -5-





                                PLC SYSTEMS INC.
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS



1.        BASIS OF PRESENTATION

         The balance  sheet as of June 30, 1996 and the  statement of operations
and cash flows for the six months ended June 30, 1996 and 1995 are unaudited and
in the opinion of management,  all adjustments necessary for a fair presentation
of such financial statements have been recorded. Such adjustments consisted only
of normal recurring items.

         Certain  information  and  footnote  disclosures  normally  included in
financial  statements  prepared in accordance with generally accepted accounting
principles have been condensed or omitted.  The year-end  balance sheet data was
derived  from audited  financial  statements,  but does not include  disclosures
required by generally accepted accounting principles. It is suggested that these
interim  financial  statements be read in  conjunction  with the Company's  most
recent Form 10-K and Annual Report as of December 31, 1995.

2.       NET INCOME (LOSS)  PER SHARE

         Net income per share is calculated using the weighted average number of
shares and share  equivalents  outstanding  during the period  which  consist of
stock options and stock warrants. The net loss per share is calculated using the
weighted  average  number of shares  outstanding  during the period and does not
include share equivalents.

3.       INVENTORY

         Inventories consist of the following (in thousands):
          
                                                      June 30,      December 31,
                                                       1996            1995
                                                     --------        ---------
           Raw materials..........................     $1,408           $ 644
           Work in process........................        508              56
           Finished goods.........................        973           1,089 
                                                       ------          ------ 
                                                       $2,889          $1,789
                                                       ======          ======

4.       STOCK WARRANTS

         On March 8, 1996,  the Company's  Form S-3 to register the common stock
underlying  the warrants  issued to the  Company's  1992  underwriters  and 1994
placement   agent  was  declared   effective  by  the  Securities  and  Exchange
Commission.  The warrant issued to the underwriters provided for the purchase of
145,000  shares at $6.00 per share and  72,500  shares at $4.80 per  share.  The
warrant  issued to the  placement  agent  provided  for the  purchase of 150,000
shares at $3.94 per share. At June 30, 1996, all of the placement  agents shares
and all but  16,770 of the  underwriters  shares had been  purchased  generating
approximately $1,660,000 in proceeds.

   

                                       -6-


ITEM 2.


                                PLC SYSTEMS INC.
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS


OVERVIEW

         The Company has two  marketing  strategies  for selling the Heart Laser
and its related  components and sterile kits;  placement and sales. In countries
where health care is reimbursed by the  government or by private  insurers,  the
Company's  strategy is to be reimbursed  for the use of the Heart Laser on a per
procedure basis under a contractual  agreement whereby the customer commits to a
minimum number of procedures on a yearly basis.  These  contracts  typically run
for a  minimum  of  three  years  and  allow  for the  customer  to  exceed  the
contractual minimums.  These contracts,  referred to as placement contracts, are
preferred  to the sale  strategy  as the  Company  believes  that the  potential
revenue  stream is greater and more  profitable.  Sterile  handpieces  and other
disposables are included in the per procedure fee. Revenues from these contracts
are classified as placement fees.

         In countries  where health care is not  reimbursed by the government or
insurance,  or where  credit  risk is high,  the Heart  Laser is sold as capital
equipment and the related  sterile  handpieces  and other  disposables  are sold
separately  for each  procedure.  The Company  sells Heart  Lasers  directly and
through distributors. These sales are classified as product sales.

RESULTS OF OPERATIONS

         Total revenues for the quarter ended June 30, 1996 were  $1,431,000,  a
decrease of 4% when compared to $1,487,000  for the quarter ended June 30, 1995.
Product sales for the quarter ended June 30, 1996 were  $769,000,  a decrease of
34% when compared to $1,164,000  for the quarter ended June 30, 1995.  The major
factor in both of these  quarterly  decreases is the  comparison  of a sale of a
Heart Laser through a distributor in the quarter ended June 30, 1996 as compared
with the direct sale of a Heart Laser  which was  recorded in the quarter  ended
June 30, 1995.

         Total  revenues  for the six  month  period  ended  June 30,  1996 were
$6,260,000,  an increase of 44% when compared to  $4,355,000  for the six months
ended June 30, 1995.  Product sales for the six month period ended June 30, 1996
were  $4,966,000,  an increase of 28% when  compared to  $3,878,000  for the six
months  ended  June 30,  1995.  The major  factors in both of these year to date
increases  are the number of Heart  Lasers  shipped  and the method of sale.  In
1996, there were 11 Heart Lasers shipped;  seven of which were sales as compared
with six shippped in 1995, five of which were sales.

         Another  factor in the year to date  increase in total  revenues is the
increase in  placement  and service  fees.  Placement  and service  fees for the
quarter  and six  months  ended  June 30,  1996 were  $662,000  and  $1,294,000,
respectively,  an  increase of 105% and 171% when  compared  with  $323,000  and
$477,000  for the same  periods  in fiscal  1995.  These  significant  increases
reflect the


                                      -7-




                                PLC SYSTEMS INC.
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                                   (Continued)


continued  acceptance of the Company's  preferred  method of sale; the placement
contract, which has increased five fold over the past twelve months.

         Total gross profit for the three and six month  periods  ended June 30,
1996  approximated  74%  and  72%,  respectively,  up  from  59% and 61% for the
comparable  periods in fiscal  1995.  These  respective  increases  of 15 and 11
percentage  points  reflect the higher  margins  associated  with the  increased
number of direct sales of Heart  Lasers in 1996 coupled with the higher  margins
generated under placement contracts.

         Selling,   general  and  administrative   spending  of  $1,591,000  and
$3,042,000  for the three and six month periods  ending June 30, 1996  increased
43% from  both of the  comparable  periods  in  fiscal  1995 of  $1,110,000  and
$2,127,000. More than half of each of these respective increases of $481,000 and
$915,000  are a  reflection  of the  investment  the  Company  has  made  in its
international sales and marketing efforts in Europe and the Pacific Rim for both
the three and six month periods.  The balance of the increases for the three and
six month  periods are related to  increased  domestic  staffing  and  increased
spending  for  consultants  related  to  health  care  reimbursement  of the TMR
procedure.

         Research  and  development  spending for the three and six months ended
June 30, 1996 was $559,000 and $1,318,000,  respectively, an increase of 11% and
5% when  compared  to  research  spending of  $503,000  and  $1,258,000  for the
comparable  periods in fiscal 1995.  These  respective  increases of $56,000 and
$60,000 reflect the continued increase in spending for scientific subsidies made
to further the study of transmyocardial revascularization.

         For the three and six  month  periods  ended  June 30,  1996,  interest
income of $161,000 and $299,000, respectively,  decreased slightly when compared
to $165,000  and  $321,000  for the  comparable  periods in fiscal  1995.  These
decreases were related to lower interest rates throughout both the three and six
month periods in 1996 as compared to the  comparable  periods in 1995.  With the
establishment  of the  Company's  subsidiary in Germany,  currency  fluctuations
between the German deutchmark and the US dollar, have resulted in a $16,000 gain
for the quarter ended June 30, 1996 and a year to date loss of $55,000.

         Although the Company  believes it has  sufficient  net  operating  loss
carryforwards to offset income taxes for the fiscal year ended December 31,1996,
a  provision  for income tax was made in the first  quarter of 1996 to cover the
tax liability  under the  alternative  minimum tax  regulations  which cannot be
offset by net operating loss carryforwards.  With the $1,095,000  operating loss
incurred in the quarter ended June 30, 1996,  this  provision  was  subsequently
adjusted.  There was no provision  for income taxes in the quarter and six month
period ended June 30, 1995 due to the operating losses incurred in both periods.

   




                                       -8-



                                PLC SYSTEMS INC.
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                                   (Continued)



         The net loss of $903,000 for the quarter ended June 30, 1996  increased
56% when  compared  to the net loss of $578,000  for the quarter  ended June 30,
1995.  This was the direct result of shipping more Heart Lasers under  placement
contracts  coupled  with  increased   operating  expenses  associated  with  the
Company's  investment  in  its  international  subsidiaries  and  the  continued
investment in TMR scientific  subsidies.  The Company's preferred method of sale
is the  placement  contract as  management  believes  the long term  revenue and
profit  potential is greater under this method as compared with the sale method.
For the six month period  ended June 30,  1996,  the Company had a net profit of
$374,000 as compared  with a net loss of $416,000 for the six month period ended
June 30, 1995.  This  improvement  is directly  related to the increase in Heart
Laser sales  coupled  with the  improved  mix of direct  sales in the six months
ended June 30, 1996 as compared to the six months ended June 30, 1995.

LIQUIDITY AND CAPITAL RESOURCES

         At June  30,  1996,  the  Company  had cash  and  cash  equivalents  of
$4,307,000 and short-term investments of $9,441,000. During the six months ended
June 30, 1996, the Company  received  approximately  $1,660,000 in proceeds from
the  exercise of stock  warrants  coupled  with  $604,000  in proceeds  from the
exercise of stock options and $110,000 from the repayment of shareholder  loans.
Cash  provided by  operations  approximated  $5,500,000  from the  collection of
$5,900,000 of accounts  receivable,  principally  the  $5,700,000  IMATRON Japan
contract offset by investment in inventory. As a result, the Company invested an
additional  $2,900,000 in short term investments.  Approximately  $1,122,000 was
used to acquire capital equipment,  principally  related to an investment in the
placement  lasers coupled with leasehold  improvements  related to the Company's
new facility.  On June 19, 1996, the Company signed a five year operating  lease
totalling   approximately   $1,482,000   for  its  new   facility  in  Franklin,
Massachusetts.

         The Company believes that existing cash balances are sufficient to meet
working  capital and  capital  expenditure  requirements  through  fiscal  1997.
However,  unanticipated decreases in operating revenues or increases in expenses
may adversely impact the Company's cash position. In the future, the Company may
seek  additional   financing  through  issuance  and  sale  of  debt  or  equity
securities,  bank financing,  joint ventures or other means. The availability of
such  financing  and the  reasonableness  of any related  terms in comparison to
market conditions cannot be assured.

         The Company believes that periodic  operating losses are possible until
after  such  time as the  Company  receives  its PMA from the FDA for the  Heart
Laser.  The Company  submitted its PMA  application in April 1995.  Although the
Heart  Laser has been  granted  "expedited  review"  status by the Food and Drug
Administration  ("FDA"), given the current uncertainties of the time required by
the FDA to approve a Premarket Approval ("PMA") application,  the Company cannot
project when, if at all,  such  approval  would be granted.  Until PMA approval,
continued profitability will likely be determined by the number of international
shipments and the related mix of sales and placements.

   



                                       -9-




                                PLC SYSTEMS INC.
                     MANAGEMENT'S DISCUSSION AND ANALYSIS OF
                  FINANCIAL CONDITION AND RESULTS OF OPERATIONS
                                   (Continued)



         In addition,  the Company must also  successfully  obtain approval from
the FDA for sale of the Heart  Laser in the  United  States,  obtain  regulatory
approval from and market the Heart Laser in certain  additional foreign markets,
and  convince  health care  professionals,  third  party  payors and the general
public of the medical and economic benefits of the Heart Laser. No assurance can
be given that the Company will be  successful  in  marketing  the Heart Laser or
that the Company will be able to operate  profitably  on a consistent  quarterly
basis.


    



                                      -10-





                                PLC SYSTEMS INC.
                            Part II Other Information




ITEM 1.  LEGAL PROCEEDINGS.

         None

ITEM 2.  CHANGES IN SECURITIES

         None

ITEM 3.  DEFAULTS BY THE COMPANY UPON ITS SENIOR SECURITIES

         None

ITEM 4.  SUBMISSION OF MATTERS TO A VOTE OF SECURITY-HOLDERS.

         On June 14,  1996,  the  Company  held its  Annual  General  Meeting of
         Stockholders to vote on the following proposals:

         1. To elect  three  members  of the Board of  Directors.  Nominees  for
            Director were: (a) Harold P. Capozzi; (b) Dr. H.B. Brent Norton; and
            (c) Dr. Roberts A. Smith ("Proposal No.1");

         2. To approve an amendment to the Corporation's  1995 Stock Option Plan
            to  increase  the  number of shares of Common  Stock  that have been
            reserved for issuance pursuant to the plan from 700,000 to 1,400,000
            ("Proposal No. 2");

         3. To appoint Ernst & Young LLP as auditors for Fiscal Year 1996 and to
            authorize  the Directors to fix the  remuneration  to be paid to the
            auditors ("Proposal No. 3").

         Of the 16,436,281  shares of the Company's Common Stock of record as of
April  26,  1996  able to be voted  at the  meeting,  a total  of  approximately
10,747,215 shares were voted, or approximately 65.4% of the Company's issued and
outstanding  shares of Common Stock entitled to vote on these  matters.  Each of
the proposals was adopted, with the vote total as follows:




                                      -11-






                                PLC SYSTEMS INC.
                     Part II Other Information - Continued

                                       SHARES          SHARES          SHARES
         PROPOSAL                     VOTING FOR    VOTING AGAINST    ABSTAINING
         --------                     ----------    --------------    ----------
         
         NO. 1

         (a) Harold P. Capozzi        10,658,101          0            89,114

         (b) Dr. H.B. Brent Norton    10,664,786          0            82,429

         (c) Dr. Roberts A. Smith     10,665,136          0            82,079


         NO. 2                         9,725,288      922,189          99,738

         NO. 3                        10,674,035       35,660          37,520


ITEM 5.  OTHER INFORMATION

         None

ITEM 6.  EXHIBITS AND REPORTS ON FORM 8-K

         a.) Exhibits

             (I) The following exhibits are filed herewith:

             Exhibit
                No.                             Title
             -------                            -----

             10a        Form of Key Employee Agreement of Robert I. Rudko.

             10b        Form of Key Employee Agreement of Max L. Hibbs.

             10c        Lease by and between Aetna Insurance Co. and PLC Medical
                        Systems, Inc. dated June 19, 1996.

             11         Statement re computation of per-share earnings.

             27         Financial Data Schedule.

         b.) Reports on Form 8-K

             None

                               
                                      -12-


                                


                                PLC SYSTEMS INC.
                            Part II Other Information
                                   (Continued)






SIGNATURES

       Pursuant to the requirements of the Securities  Exchange Act of 1934, the
registrant  has duly  caused  this  report  to be  signed  on its  behalf by the
undersigned thereunto duly authorized.




                                                      PLC SYSTEMS INC.
                                                      Registrant



Date:    August 13, 1996                               /s/  Patricia L. Murphy
      -----------------------                          -------------------------
                                                       Patricia L. Murphy
                                                       (Chief Financial Officer)

    

                                      -13-